Document Classification

Section Type: RESULTS

Text: (1) No significant between-group difference of age, gender, smoking, previous glucocorticoid use and hemoglobin level was found ; (2) after 10. 60. 8 d of PPI therapy, BMD T score in the controlled group was slightly increased compared with initial (-1. 250. 08 versus -1. 280. 06, p = 0. 084), while there was no change in the supplemented group (-1. 250. 05 versus -1. 260. 03, p = 0. 308) ; (3) during study termination, calcium level in the supplemented group was slightly higher than the controlled group (2. 050. 03 mmol/L versus 2. 010. 05 mmol/L, p = 0. 073), while no significant differences of CTX (366. 5743. 71 pg/mL versus 373. 1550. 23 pg/mL, p = 0. 036) and ALP were found among these two groups (50. 479. 32 U/L versus 52. 2310. 45 U/L, p = 0. 075).